LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy (LONGBOARD)
Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group
This PHASE2 trial investigates Metastatic Colorectal Cancer and is currently ongoing. GERCOR - Multidisciplinary Oncology Cooperative Group leads this study, which shows 14 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Oct 2023 — Apr 2024 [monthly]
Recruiting PHASE2
▶ Show 9 earlier versions
-
Apr 2023 — Oct 2023 [monthly]
Recruiting PHASE2
Status: Unknown Status → Recruiting
-
Feb 2023 — Apr 2023 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Feb 2021 — Feb 2023 [monthly]
Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Aug 2020 — Dec 2020 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE2
-
Mar 2020 — May 2020 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2019 — Mar 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- GERCOR - Multidisciplinary Oncology Cooperative Group
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Amiens, France , Angers, France , Besançon, France , Beuvry, France , Bordeaux, France , Chauny, France , Compiègne, France , Coudekerque-Branche, France , Créteil, France , Dijon, France and 10 more locations